Harbin Fuerjia Technology Co., Ltd. (SHE:301371)
21.64
+0.14 (0.65%)
At close: Sep 8, 2026
Harbin Fuerjia Technology Revenue
Harbin Fuerjia Technology had revenue of 607.85M CNY in the quarter ending June 30, 2026, with 8.15% growth. This brings the company's revenue in the last twelve months to 2.19B, up 12.67% year-over-year. In the year 2025, Harbin Fuerjia Technology had annual revenue of 1.89B, down -6.14%.
Revenue (ttm)
2.19B
Revenue Growth
+12.67%
P/S Ratio
5.15
Revenue / Employee
n/a
Employees
751
Market Cap
11.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.89B | -123.83M | -6.14% |
| Dec 31, 2024 | 2.02B | 83.47M | 4.32% |
| Dec 31, 2023 | 1.93B | 164.29M | 9.29% |
| Jan 1, 2023 | 1.77B | 119.53M | 7.25% |
| Dec 31, 2021 | 1.65B | 64.67M | 4.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Eternal Asia Supply Chain Management | 57.07B |
| NORINCO International Cooperation | 12.25B |
| Skyworth Digital | 10.09B |
| Weichai Heavy Machinery | 7.62B |
| Aerospace Hi-Tech Holding Group | 4.80B |
| Suzhou SLAC Precision Equipment CO.,Ltd. | 2.28B |
| Tibet Cheezheng Tibetan Medicine | 2.22B |
| Sino Biological,Inc. | 768.00M |